MiR-375 Activates P21 and Suppresses Telomerase Activity by Coordinately Regulating HPV E6/E7, E6AP, CIP2A, and 14-3-3ζ
Overview
Oncology
Affiliations
Background: While microRNAs (miRNAs) are extensively studied in post-transcriptional regulation of gene expressions in many biological processes, cellular miRNA-mediated regulation of viral genes remains unclear. In particular, the interplay between human papillomavirus (HPV) genes and miRNAs and how these interactions contribute to HPV-associated cancers remain elusive.
Methods: Transient transfection of miR-375-mimic was used to compensate the loss-of-function of miR-375 in HPV-positive cancer. Regulation of oncogenic molecules and their downstream molecules via miR-375 in HPV-positive cancer was investigated using qRT-PCR, western blot, dual luciferase assay, indirect immunofluorescence analysis. All experiments were conducted at least three times to achieve statistical significance determined by Student t-test.
Results: In this study, we demonstrated how miR-375 negatively regulates HPV16 and 18 transcripts. We also found a cellular protein, E6-associated protein (E6AP), directly regulated by miR-375. miR-375-mediated repression of HPV transcripts and E6AP elevated major tumor suppressors p53, p21, and retinoblastoma protein 1 (RB). Cooperative regulation of miR-375 targets along with the increase of tumor suppressors led to ~60% reduction of telomerase reverse transcriptase (TERT) transcription followed by ~35% decrease of telomerase activity. Furthermore, miR-375-mediated regulation of 14-3-3ζ contributes to decrease telomerase activity by altering nuclear translocation of TERT.
Conclusion: Taken together, miR-375-mediated suppression of multiple oncogenic components in HPV-associated carcinogenesis generates a cumulative biological response to rescue key tumor suppressors and diminish telomerase activity, which results in cell cycle arrest and cell proliferation inhibition.
Balamurli G, Liew A, Tee W, Pervaiz S Redox Biol. 2024; 78:103441.
PMID: 39612910 PMC: 11629570. DOI: 10.1016/j.redox.2024.103441.
MicroRNAs role in telomere length maintenance and telomerase activity in tumor cells.
Bortoletto S, Nunes-Souza E, Marchi R, Ruthes M, Okano L, Tofolo M J Mol Med (Berl). 2024; 102(9):1089-1100.
PMID: 39042290 DOI: 10.1007/s00109-024-02467-z.
Protein Phosphatase 2A as a Therapeutic Target in Pulmonary Diseases.
Yu H, Zaveri S, Sattar Z, Schaible M, Perez Gandara B, Uddin A Medicina (Kaunas). 2023; 59(9).
PMID: 37763671 PMC: 10535831. DOI: 10.3390/medicina59091552.
Small Molecule Inhibitors of Human Papillomavirus: A Review of Research from 1997 to 2021.
Duncan C, Gunosewoyo H, Mocerino M, Payne A Curr Med Chem. 2023; 31(33):5308-5350.
PMID: 37448363 DOI: 10.2174/0929867331666230713165407.
Chen B, Hu H, Chen X Front Genet. 2023; 14:1110656.
PMID: 36911405 PMC: 9998691. DOI: 10.3389/fgene.2023.1110656.